AbelZeta Pharma
abelzeta.com
Health Care
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
HongShan
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
SOLA Biosciences develops JUMP70 platform therapies targeting protein misfolding in ALS, Parkinson’s, and other conformational diseases.
Invest in cutting-edge immunotherapy solutions targeting cancers and rheumatic diseases.
Bioarchitech develops multifunctional immunotherapies targeting cancer and virus-related diseases, including innovative viral and RNA-based…
Developing therapies targeting adaptive-stress driven vulnerabilities to combat treatment resistance, cancer relapse, and metastasis.
Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
Transforming lives with pioneering antibody science. Previous.
Overview
Discover AbelZeta Pharma's global leadership in pioneering T cell-based therapies targeting cancer, inflammation, & immunological issues, advancing healthcare with innovative solutions.